venBio Partners portfolio
venBio Partners (Venture capital) is known to hold 44 companies, 16 of them startups. 16 of them are hiring now, with 3,145 open roles. Its companies closed 1 venture rounds in 12 months, raising $10M. Most of them work in Biologics & Biosimilars, Prescription Drugs, Oncology Therapeutics.
Companies venBio Partners has invested in
Open roles at venBio Partners portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about venBio Partners
How many companies has venBio Partners invested in?
venBio Partners is known to hold 44 companies: 16 startups, and 16 exits so far, read from its own portfolio page and the funding rounds that name it.
Is venBio Partners investing now?
venBio Partners has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does venBio Partners invest in?
The markets of the companies venBio Partners holds: Biologics & Biosimilars (20%), Prescription Drugs (18%), Oncology Therapeutics (16%), Immunology & Inflammation Therapeutics (11%), Cardiometabolic Therapeutics (9%).
Which venBio Partners portfolio companies are hiring?
16 companies venBio Partners holds are hiring now, with 3,145 open roles listed on this page.
Who does venBio Partners invest alongside?
The investors that hold the most companies together with venBio Partners: RA Capital Management, Foresite Capital, NEA, Nextech Invest, Wellington Management.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 3
venBio Partners portfolio: 44 known companies. Alion, Oct 19, 2026. https://alion.io/company/venbio-partners/portfolio
